Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis.
Fluconazole is a new triazole antifungal agent with good activity against Candida and cryptococcal meningitis. It is well-tolerated and effective in immunosuppressed patients with oral-pharyngeal candidiasis. This review outlines the characteristics of fluconazole and discusses its role among the class of antifungal agents.
Garber
G E
GE
Department of Medicine, Ottawa General Hospital, Ontario, Canada.
D002177:Candidiasis / Q000150:complications / Q000188:drug therapy*; D002180:Candidiasis, Oral / Q000188:drug therapy; D004935:Esophageal Diseases / Q000188:drug therapy*; D015725:Fluconazole / Q000494:pharmacology / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D009061:Mouth Mucosa / Q000382:microbiology
D015725:Fluconazole